Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

HUTCHMED

Hematology

Hematology Today—May 4, 2026

This week’s Hematology update highlights regulatory progress, clinical data…

Hematology

Hematology Today—March 23, 2026

This week’s Hematology update highlights hemophilia gene therapy supply…

Onco_background

Oncology Today—January 5, 2026

This oncology roundup captures major regulatory approvals, strategic portfolio…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Hematology Today—May 25, 2026
Oncology Today—May 25, 2026
Lucid Diligence Brief: Genethon and Ampersand Biomedicines AAV Partnership
Lucid Diligence Brief: Gilead To Acquire Tubulis to Expand Oncology ADC Pipeline
Vaccines Today—May 22, 2026

Tags

AI Assisted Chest X Ray ambient scribe anti-aging ARIKAYCE breast cancer genomics CAD cancer care cancer vaccines cardiovascular-kidney-metabolic syndrome Chemotherapy China NMPA chronic rhinosinusitis with nasal polyps competitive advantage CORD cryo-EM Daewoong Daewoong Pharmaceutical Diabetes drug development evinova hair loss treatments HeartFlow homozygous familial hypercholesterolemia insulin glargine international atherosclerosis society Intracranial atherosclerosis Li Fraumeni syndrome Merck & Co. Mucosal immunity myocardial infarction olid Biosciences oral therapies Oxford Pain pharmacogenomics Phenylketonuria renal stones Revolution Medicines risankizumab SciSparc target discovery Tecvayli Tether QVAC Health Thrombotic thrombocytopenic purpura TRIUMPH-4 urticaria

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Hematology Today—May 25, 2026
Oncology Today—May 25, 2026
Lucid Diligence Brief: Genethon and Ampersand Biomedicines AAV Partnership
Lucid Diligence Brief: Gilead To Acquire Tubulis to Expand Oncology ADC Pipeline
Vaccines Today—May 22, 2026

TAGS

AI Assisted Chest X Ray ambient scribe anti-aging ARIKAYCE breast cancer genomics CAD cancer care cancer vaccines cardiovascular-kidney-metabolic syndrome Chemotherapy China NMPA chronic rhinosinusitis with nasal polyps competitive advantage CORD cryo-EM Daewoong Daewoong Pharmaceutical Diabetes drug development evinova hair loss treatments HeartFlow homozygous familial hypercholesterolemia insulin glargine international atherosclerosis society Intracranial atherosclerosis Li Fraumeni syndrome Merck & Co. Mucosal immunity myocardial infarction olid Biosciences oral therapies Oxford Pain pharmacogenomics Phenylketonuria renal stones Revolution Medicines risankizumab SciSparc target discovery Tecvayli Tether QVAC Health Thrombotic thrombocytopenic purpura TRIUMPH-4 urticaria

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy